Justin Verlander is living an affluent lifestyle owing to humongous earnings he made from his 22-season-long baseball career. The 2011 MVP has built v ...

GSK and ABL Bio have entered into an agreement worth over £2bn to develop new drugs for neurodegenerative ... as well as tiered royalties on future net sales. Christopher Austin, senior vice president ...

A Ministry of Commerce task force is collecting lists of items that could be exempted from tariffs and is asking companies to submit their own requests ...

Amid the current market turmoil, it is worth remembering that the pharmaceutical industry must continue its normal business of ensuring that it has products to sell in 10 years, with GSK (GSK ...

Abstract Title: Preliminary results from the randomized phase 2 study (1801 part 3B) of elraglusib in combination with ...

A string of pharmaceutical bosses attended a three-hour dinner at Donald Trump’s Mar-a-Lago resort in Florida in December.

Just months after it started trading on the Nasdaq in June 2021, the company was valued as high as $5.8 billion. As of Friday, the firm’s shares were worth less than a dollar.

Donald Trump has vowed to hit imports of pharmaceuticals with new tariffs in a major setback for one of Britain’s largest ...

CureVac N.V.'s restructuring deal with GSK and workforce reduction suggest financial struggles, with net losses reported ... management must believe that it is worth the effort, even while ...

GSK is responsible for the development and commercialization of Jemperli, while AnaptysBio is entitled to receive milestone payments and tiered royalties on annual net sales of the drug.

Entrepreneurship is often portrayed as glamorous, adventurous, and liberating. What is less often discussed is the loneliness ...